4//SEC Filing
Reich Siegfried 4
Accession 0001209191-21-009364
CIK 0001595893other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:55 PM ET
Size
7.2 KB
Accession
0001209191-21-009364
Insider Transaction Report
Form 4
Reich Siegfried
EVP & Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-08+17,303→ 17,303 totalExercise: $140.01Exp: 2031-02-07→ Common Stock (17,303 underlying) - Award
Common Stock
2021-02-08+3,845→ 3,845 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/48th of the shares vest monthly following February 8, 2021.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001351888
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:55 PM ET
- Size
- 7.2 KB